Introduction
Materials and methods
RNU | SU |
p value | |
---|---|---|---|
Patient number | 77 | 35 | |
Follow-up duration (months) | 43.84 ± 20.64 | 48.26 ± 26.97 | 0.344 |
Age | 66.71 ± 9.96 | 69.29 ± 9.44 | 0.201 |
Male/female | 41/36 | 18/17 | 0.858 |
High grade | 68 (88.3 %) | 30 (85.7 %) | 0.700 |
Multifocality | 17 (22 %) | 2 (5.7 %) | 0.032 |
Preoperative eGFR | 54.60 ± 28.78 | 56.31 ± 33.62 | 0.522 |
Postoperative eGFR change | −10.66 ± 24.5 | 1.18 ± 14.9 | 0.011 |
Bladder cancer history | 16 (20.8 %) | 8 (22.9 %) | 0.804 |
Non-organ confined (>T2) | 15 (19.5 %) | 11 (31.4 %) | 0.165 |
Bladder recurrence | 28 (36.4 %) | 12 (34.2 %) | 0.832 |
Local recurrence | 18 (23.4 %) | 5 (14.3 %) | 0.270 |
Distant metastasis | 13 (16.9 %) | 3 (8.6 %) | 0.244 |
Cancer death | 10 (13.0 %) | 2 (5.7 %) | 0.249 |
Results
Bladder recurrence | Local recurrence | |||
---|---|---|---|---|
Univariate
p value | Multivariate
p value | Univariate
p value | Multivariate
p value | |
Surgical intervention RNU/SU | 0.832 | 0.270 | ||
Organ confinement >T2/≤T2 | 0.894 | <0.001 | <0.001 HR 9.4, 95 % CI 2.8–31.8 | |
Tumor grade High/low | 0.551 | 0.185 | ||
Smoking Yes/no | 0.035 | 0.033 HR 3.7, 95 % CI 1.1–11.9 | 0.187 | |
Multifocality Yes/no | 0.027 | 0.074 | 0.001 | 0.047 HR 3.9, 95 % CI 1.1–14.8 |
Bladder cancer history Yes/no | 0.009 | 0.025 HR 3.2, 95 % CI 1.2–8.6 | 0.968 |
Distant metastasis | Cancer death | |||
---|---|---|---|---|
Univariate
p value | Multivariate
p value | Univariate
p value | Multivariate
p value | |
Surgical intervention RNU/SU | 0.244 | 0.249 | ||
Organ confinement >T2/≦T2 | 0.006 | 0.002 HR 11.2, 95 % CI 2.5–50.8 | 0.002 | 0.007 HR 8.8, 95 % CI 1.8–43.2 |
Tumor grade High/low | 0.414 | 0.166 | ||
Smoking Yes/no | 0.023 | 0.012 HR 6.2, 95 % CI 1.5–25.6 | 0.212 | |
Multifocality Yes/no | 0.837 | 0.016 | 0.474 | |
Bladder cancer history Yes/no | 0.301 | 0.287 |